Sea Crest Wealth Management, LLC Regenxbio Inc. Transaction History

Sea Crest Wealth Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	BUY	$19.35 - $35.04 $16,157 - $29,258	835 New	835 $21,000
Q2 2019 Jul 19, 2019	SELL	$42.0 - $59.29 $2,100 - $2,964	-50 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$40.82 - $62.45 $1,428 - $2,185	35 Added 233.33%	50 $3,000
Q3 2018 Nov 14, 2018	BUY	$65.0 - $82.15 $975 - $1,232	15 New	15 $1,000

192

43.2M

104K

478K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $319M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Sea Crest Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sea Crest Wealth Management, LLC with notifications on news.